NL-OMON29554招募中不适用
Dual thrombolytic therapy with mutant pro-urokinase and low dose alteplase for ischemic stroke
Erasmus Medical Center, ROtterdam0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
one
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A clinical diagnosis of ischemic stroke;
- •-A score of at least 1 on the NIH Stroke Scale;
排除标准
- •-Candidate for endovascular thrombectomy (i.e., a proximal intracranial large artery occlusion on CTA);
- •-Contra-indication for standard treatment with IV alteplase according to national guidelines;
研究者
相似试验
招募中
2 期
Dual thrombolytic therapy with mutant pro-urokinase (m-pro-urokinase, HisproUK) and low dose alteplase for ischemic strokebrain infarctionIschemic Stroke1000796310014523NL-OMON55848Erasmus MC, Universitair Medisch Centrum Rotterdam240
已完成
2 期
Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic StrokeIschemic StrokeNCT04256473Erasmus Medical Center200
终止
早期 1 期
Research Into the Effect of a Clot-dissolving Agent and Its InhibitorAcute Ischemic StrokeNCT01694381TSI, LLC8
尚未招募
不适用
Intrapleural fibrinolytic therapy with urokinase.Refractory intrathoracic infectionJPRN-UMIN000031102Gunma University30
已完成
不适用
Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective StudyAcute Ischemic Stroke Due to Medium-vessel-occlusionNCT05809921Centre Hospitalier Sud Francilien294